Lipocine Inc. — Director's Dealing 2023

Mar 20, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lipocine Inc. (LPCN)
CIK: 0001535955
Period of Report: 2023-03-20

Reporting Person: Ono Richard Dana (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-03-20	Common Stock	P	4000	$0.34	Acquired	14125	Direct